IP Library Granted Patent US 10,925,554
Granted Patent B2
US 10,925,554 · App. 15/533,749 · Granted Feb 23, 2021

Outside-FOV activity estimation using surview and prior patient data in positron emission tomography

Inventors: Andriy Andreyev (Willoughby Hills, OH); Manoj Narayanan (Mentor, OH); Bin Zhang (Cleveland, OH); Zhiqiang Hu (Twinsburg, OH); Yu-Lung Hsieh (Aurora, OH); Xiyun Song (Cupertino, CA); Jinghan Ye (Cupertino, CA)
Assignee: KONINKLIJKE PHILIPS N.V.
A61B6/037A61B5/0077A61B5/055A61B6/032A61B6/4258A61B6/4417A61B6/483A61B6/488A61B6/5205A61B6/5247A61B6/5282G01T1/1603G06T11/005G06T2211/432
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,925,554
App. No.
15/533,749
Granted
Feb 23, 2021
Kind
B2
Abstract

A radioemission scanner ( 12 ) is operated to acquire tomographic radioemission data of a radiopharmaceutical in a subject in an imaging field of view (FOV). An imaging system is operated to acquire extension imaging data of the subject in an extended FOV disposed outside of and adjacent the imaging FOV along an axial direction ( 18 ). A distribution of the radiopharmaceutical in the subject in the extended FOV is estimated based on the extension imaging data, and further based on a database ( 32 ) of reference subjects. The tomographic radioemission data are reconstructed to generate a reconstructed image ( 26 ) of the subject in the imaging FOV. The reconstruction includes correcting the reconstructed image for scatter from the extended FOV into the imaging FOV based on the estimated distribution of the radiopharmaceutical in the subject in the extended FOV.

Claims (56)

1. A radioemission imaging system comprising:

a database; and

an electronic data processing device programmed to perform an imaging method including:

operating a radioemission scanner to acquire tomographic radioemission data of a radiopharmaceutical in a subject in an imaging field of view (FOV);

operating an imaging system to acquire extension imaging data of the subject in an extended FOV disposed outside of and adjacent the imaging FOV along an axial direction;

estimating a distribution of the radiopharmaceutical in the subject in the extended FOV based on the extension imaging data including selecting, from the database, a distribution of the radiopharmaceutical in other subjects; and

reconstructing the tomographic radioemission data to generate a reconstructed image of the subject in the imaging FOV including correcting the reconstructed image for scatter from the extended FOV into the imaging FOV based on the estimated distribution of the radiopharmaceutical in the subject in the extended FOV.

2. The radioemission imaging system of claim 1 wherein:

the operating of an imaging system to acquire extension imaging data comprises operating a transmission computed tomography (CT) scanner or magnetic resonance (MR) scanner or optical imaging device scanner to acquire an image of the subject in the extended FOV; and

the estimating comprises estimating the distribution of the radiopharmaceutical in the subject in the extended FOV based on (i) the acquired image of the subject in the extended FOV and (ii) the selected distributions of the radiopharmaceutical in other subjects from the database.

3. The radioemission imaging system of claim 1 wherein:

the operating of an imaging system to acquire extension imaging data comprises operating the radioemission scanner to acquire two- or three-dimensional radioemission data of the radiopharmaceutical in the subject in the extended FOV; and

the estimating comprises estimating a three-dimensional distribution of the radiopharmaceutical in the subject in the extended FOV based on (i) the acquired two- or three-dimensional radioemission data of the subject in the extended FOV and (ii) three-dimensional distributions of the radiopharmaceutical in other subjects stored in the database.

4. The radioemission imaging system of claim 2 wherein the estimating comprises selecting, from the database, a distribution of the radiopharmaceutical in another subject that most closely matches element (i).

5. The radioemission imaging system of claim 4 wherein the estimating further comprises adjusting the selected distribution of the radiopharmaceutical in another subject based on at least one of:

element (i), and

a characteristic of the subject.

6. The radioemission imaging system of claim 1 wherein:

the operating of an imaging system to acquire extension imaging data comprises operating the radioemission scanner to acquire a whole-body radioemission image of the subject that encompasses the extended FOV wherein the whole-body image is of lower resolution than the reconstructed image; and

the estimating comprises estimating the distribution of the radiopharmaceutical in the subject in the extended FOV based on the whole-body radioemission image of the subject.

7. The radioemission imaging system of claim 1 further comprising:

a positron emission tomography (PET) scanner, wherein the radioemission scanner is the PET scanner.

8. The radioemission imaging system of claim 1 wherein the correcting comprises correcting the reconstructed image for the estimated distribution of the radiopharmaceutical in the subject in the extended FOV using single scatter simulation (SSS).

9. A non-transitory storage medium storing instructions readable and executable by an electronic data processing device to perform an imaging method including:

receiving tomographic radioemission data of a radiopharmaceutical in a subject in an imaging field of view (FOV);

receiving extension imaging data of the subject in an extended FOV neighboring the imaging FOV;

estimating a distribution of the radiopharmaceutical in the subject in the extended FOV based on the extension imaging data including selecting, from a database, a distribution of the radiopharmaceutical in other subjects and estimating the distribution of the radiopharmaceutical in the subject based on the distribution of the radiopharmaceutical in other subjects selected from the database; and

reconstructing the tomographic radioemission data to generate a reconstructed image of the subject in the imaging FOV;

wherein the reconstructing includes correcting the reconstructed image for scatter from the estimated distribution of the radiopharmaceutical in the subject in the extended FOV.

10. The non-transitory storage medium according to claim 9 wherein the imaging method further includes:

acquiring extension imaging data from a transmission computed tomography (CT) scanner or magnetic resonance (MR) scanner or optical imaging device of an image of the subject in the extended FOV; and

wherein the estimating further comprises estimating the distribution of the radiopharmaceutical in the subject in the extended FOV based on (i) the acquired image of the subject in the extended FOV and (ii) of the selected distributions of the radiopharmaceutical in other subjects from the database.

11. The non-transitory storage medium according to claim 9 wherein the imaging method further includes:

acquiring low statistics ultrafast scan radioemission data of the radiopharmaceutical in the subject in the extended FOV; and

wherein the estimating further comprises estimating a three-dimensional distribution of the radiopharmaceutical in the subject in the extended FOV based on (i) the acquired low statistics radioemission data of the subject in the extended FOV and (ii) three-dimensional distributions of the radiopharmaceutical in other subjects stored in the database.

12. The radioemission imaging system of claim 10 wherein the estimating further comprises selecting, from the database, a distribution of the radiopharmaceutical in another subject that most closely matches element (i).

13. The radioemission imaging system of claim 12 wherein the estimating further comprises adjusting the selected distribution of the radiopharmaceutical in another subject based on at least one of: element (i), and characteristics of the subject.

14. The non-transitory storage medium according to claim 9 wherein the imaging method further includes:

acquiring a whole-body radioemission image of the subject that encompasses the extended FOV wherein the whole-body image is of lower resolution than the reconstructed image; and

wherein the estimating further comprises estimating the distribution of the radiopharmaceutical in the subject in the extended FOV based on the whole-body radioemission image of the subject.

15. An imaging method including:

acquiring tomographic radioemission data of a radiopharmaceutical in a subject in an imaging field of view (FOV);

acquiring extension imaging data of the subject in an extended FOV extending beyond the imaging FOV along an axial direction;

estimating a distribution of the radiopharmaceutical in the subject in the extended FOV based on the extension imaging data including selecting, from a database, a distribution of the radiopharmaceutical in other subjects; and

reconstructing the tomographic radioemission data to generate a reconstructed image of the subject in the imaging FOV including correcting the reconstructed image for scatter into the imaging FOV from the estimated distribution of the radiopharmaceutical in the subject in the extended FOV.

16. The method of claim 15 further including:

acquiring extension imaging data from a transmission computed tomography (CT) scanner or magnetic resonance (MR) scanner of an image of the subject in the extended FOV; and

wherein the estimating further comprises estimating the distribution of the radiopharmaceutical in the subject in the extended FOV based on (i) the acquired image of the subject in the extended FOV and (ii) of the selected distributions of the radiopharmaceutical in other subjects from the database.

17. The method of claim 15 further including:

acquiring two-dimensional radioemission data of the radiopharmaceutical in the subject in the extended FOV; and

wherein the estimating further comprises estimating a three-dimensional distribution of the radiopharmaceutical in the subject in the extended FOV based on (i) the acquired two-dimensional radioemission data of the subject in the extended FOV and (ii) three-dimensional distributions of the radiopharmaceutical in other subjects stored in the database.

18. The method of claim 16 wherein the estimating further comprises selecting, from the database, a distribution of the radiopharmaceutical in another subject that most closely matches element (i).

19. The method of claim 18 wherein the estimating further comprises adjusting the selected distribution of the radiopharmaceutical in another subject based on at least one of: element (i), and a characteristic of the subject.

20. The method of claim 15 further including:

acquiring a whole-body radioemission image of the subject that encompasses the extended FOV wherein the whole-body image is of lower resolution than the reconstructed image; and

wherein the estimating further comprises estimating the distribution of the radiopharmaceutical in the subject in the extended FOV based on the whole-body radioemission image of the subject.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2017
From: ANDREYEV, ANDRIY; NARAYANAN, MANOJ; ZHANG, BIN; HU, ZHIQIANG; HSIEH, YU-LUNG; SONG, XIYUN; YE, JINGHAN
To: KONINKLIJKE PHILIPS N.V.
Reel/Frame 042635/0120 →
Continuity (2)
Provisional Application 62089879 · Dec 10, 2014
Related Publication 20170319154A1 · Nov 9, 2017